Risk factor
Vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITD
Target Price
The average target price of VMD is 15 and suggests 63% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell